Singapore markets open in 6 hours 39 minutes

Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
88.20-1.80 (-2.00%)
At close: 12:33PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
121,183
121,183
65,820
44,672
72,230
Selling general and administrative
13,511
13,511
-
-
-
Total operating expenses
134,617
134,617
65,808
44,578
71,918
Operating income or loss
-134,617
-134,617
-65,808
-44,578
-71,918
Interest expense
0
0
293
413
303
Income before tax
-123,068
-123,068
-65,451
-44,991
-72,007
Income from continuing operations
-123,068
-123,068
-65,451
-44,991
-72,007
Net income
-123,068
-123,068
-65,451
-44,991
-72,007
Net income available to common shareholders
-123,068
-123,068
-65,451
-44,991
-72,007
Basic EPS
-5.83
-9.95
-5.83
-4.01
-6.41
Diluted EPS
-5.83
-9.95
-5.83
-4.01
-6.41
Basic average shares
11,226
12,365
11,226
11,226
11,226
Diluted average shares
11,226
12,365
11,226
11,226
11,226